Form 8-K - Current report:
SEC Accession No. 0001601830-24-000232
Filing Date
2024-12-03
Accepted
2024-12-03 16:40:55
Documents
14
Period of Report
2024-12-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K rxrx-20241202.htm   iXBRL 8-K 22155
  Complete submission text file 0001601830-24-000232.txt   157188

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20241202.xsd EX-101.SCH 2042
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rxrx-20241202_def.xml EX-101.DEF 2843
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20241202_lab.xml EX-101.LAB 23477
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20241202_pre.xml EX-101.PRE 14135
17 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20241202_htm.xml XML 2746
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 241523363
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)